Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease

被引:1
|
作者
Bianchi, Alessia [1 ,2 ,3 ]
Cortese, Rosa [2 ,3 ]
Prados, Ferran [2 ,4 ,5 ]
Tur, Carmen [2 ,6 ]
Kanber, Baris [2 ,4 ]
Yiannakas, Marios C. [2 ]
Samson, Rebecca [2 ]
De Angelis, Floriana [2 ]
Magnollay, Lise [2 ]
Jacob, Anu [7 ,8 ]
Brownlee, Wallace [2 ,9 ]
Trip, Anand [2 ,9 ]
Nicholas, Richard [10 ]
Hacohen, Yael [2 ,11 ]
Barkhof, Frederik [2 ,4 ,9 ,12 ]
Ciccarelli, Olga [2 ,9 ]
Toosy, Ahmed T. [2 ]
机构
[1] UCL, UCL Queen Sq Inst Neurol, Fac Brain Sci, Queen Sq MS Ctr,Dept Neuroinflammat, London WC1N 3BG, England
[2] UCL, UCL Queen Sq Inst Neurol, Fac Brain Sci, Queen Sq MS Ctr,Dept Neuroinflammat, London, England
[3] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy
[4] UCL, Ctr Med Image Comp Med Phys & Biomed Engn, London, England
[5] Univ Oberta Catalunya, eHlth Ctr, Barcelona, Spain
[6] Vall dHebron Barcelona Hosp Campus, Vall dHebron Inst Res, MS Ctr Catalonia Cemcat, Barcelona, Spain
[7] Walton Ctr NHS Fdn Trust, Dept Neurol, Liverpool, England
[8] Cleveland Clin Abu Dhabi, Dept Neurol, Abu Dhabi, U Arab Emirates
[9] Univ Coll London Hosp UCLH, Natl Inst Hlth Res NIHR, Biomed Res Ctr, London, England
[10] Imperial Coll London, Dept Med, Div Brain Sci, London, England
[11] Great Ormond St Hosp Children NHS Fdn Trust, Dept Neurol, London, England
[12] Vrije Univ Amsterdam, Dept Radiol & Nucl Med, Amsterdam UMC, Amsterdam, Netherlands
关键词
Optic chiasm; optic neuritis; multiple sclerosis; aquaporin4-antibody neuromyelitis optica spectrum disorder; myelin oligodendrocyte glycoprotein antibody-associated disease; magnetisation transfer ratio; MAGNETIZATION-TRANSFER; COHERENCE TOMOGRAPHY; DIAGNOSIS;
D O I
10.1177/13524585241240420
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Optic neuritis (ON) is a common feature of inflammatory demyelinating diseases (IDDs) such as multiple sclerosis (MS), aquaporin 4-antibody neuromyelitis optica spectrum disorder (AQP4 + NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). However, the involvement of the optic chiasm (OC) in IDD has not been fully investigated.Aims: To examine OC differences in non-acute IDD patients with (ON+) and without ON (ON-) using magnetisation transfer ratio (MTR), to compare differences between MS, AQP4 + NMOSD and MOGAD and understand their associations with other neuro-ophthalmological markers.Methods: Twenty-eight relapsing-remitting multiple sclerosis (RRMS), 24 AQP4 + NMOSD, 28 MOGAD patients and 32 healthy controls (HCs) underwent clinical evaluation, MRI and optical coherence tomography (OCT) scan. Multivariable linear regression models were applied.Results: ON + IDD patients showed lower OC MTR than HCs (28.87 +/- 4.58 vs 31.65 +/- 4.93; p = 0.004). When compared with HCs, lower OC MTR was found in ON + AQP4 + NMOSD (28.55 +/- 4.18 vs 31.65 +/- 4.93; p = 0.020) and MOGAD (28.73 +/- 4.99 vs 31.65 +/- 4.93; p = 0.007) and in ON- AQP4 + NMOSD (28.37 +/- 7.27 vs 31.65 +/- 4.93; p = 0.035). ON+ RRMS had lower MTR than ON- RRMS (28.87 +/- 4.58 vs 30.99 +/- 4.76; p = 0.038). Lower OC MTR was associated with higher number of ON (regression coefficient (RC) = -1.15, 95% confidence interval (CI) = -1.819 to -0.490, p = 0.001), worse visual acuity (RC = -0.026, 95% CI = -0.041 to -0.011, p = 0.001) and lower peripapillary retinal nerve fibre layer (pRNFL) thickness (RC = 1.129, 95% CI = 0.199 to 2.059, p = 0.018) when considering the whole IDD group.Conclusion: OC microstructural damage indicates prior ON in IDD and is linked to reduced vision and thinner pRNFL.
引用
收藏
页码:674 / 686
页数:13
相关论文
共 50 条
  • [41] MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease
    Cortese, Rosa
    Giorgio, Antonio
    Severa, Gianmarco
    De Stefano, Nicola
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [42] Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan
    Niino, Masaaki
    Isobe, Noriko
    Araki, Manabu
    Ohashi, Takashi
    Okamoto, Tomoko
    Ogino, Mieko
    Okuno, Tatsusada
    Ochi, Hirofumi
    Kawachi, Izumi
    Shimizu, Yuko
    Takahashi, Kazuya
    Takeuchi, Hideyuki
    Tahara, Masayuki
    Chihara, Norio
    Nakashima, Ichiro
    Fukaura, Hikoaki
    Misu, Tatsuro
    Miyazaki, Yusei
    Miyamoto, Katsuichi
    Mori, Masahiro
    Kinoshita, Makoto
    Takai, Yoshiki
    Fujii, Chihiro
    Watanabe, Mitsuru
    Fujihara, Kazuo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 90
  • [43] New T2 silent lesions in myelin-oligodendrocyte-glycoprotein antibody disease and aquaporin-4 antibody neuromyelitis optica spectrum disorders
    Camera, V.
    Holm-Mercer, L.
    Asgar, H. A. A.
    Messina, S.
    Kuker, W.
    Leite, M. I.
    Palace, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 11 - 11
  • [44] Galactorrhea in a Patient With Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder A Case Report and Review of the Literature
    Watanabe, Masahiko
    Furusho, Kentaro
    Takahashi, Toshiyuki
    Tamaoka, Akira
    NEUROLOGIST, 2015, 20 (06) : 101 - 103
  • [46] Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
    Patrick Schindler
    Ulrike Grittner
    Johanna Oechtering
    David Leppert
    Nadja Siebert
    Ankelien S. Duchow
    Frederike C. Oertel
    Susanna Asseyer
    Joseph Kuchling
    Hanna G. Zimmermann
    Alexander U. Brandt
    Pascal Benkert
    Markus Reindl
    Sven Jarius
    Friedemann Paul
    Judith Bellmann-Strobl
    Jens Kuhle
    Klemens Ruprecht
    Journal of Neuroinflammation, 18
  • [47] Comparison of Clinical Features of Aquaporin-4 Positive Neuromyelitis Optica Spectrum Disorder (NMOSD), Myelin Oligodendrocyte Glycoprotein (MOG) Associated Disorder, and Seronegative NMOSD - A Single Center Experience
    Ozbek, Ezgi Demirel
    Cakan, Melike
    Acar, Nazire Pinar
    Colpak, Ayse Ilksen
    Kasikci, Merve
    Karabudak, Rana
    Tuncer, Meryem Asli
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 660 - 661
  • [48] Frequency, characteristics and outcomes of myelin oligodendrocyte glycoprotein-antibody-associated-disorder (MOGAD) and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder (AQP4-NMOSD) attacks requiring ventilatory support
    Zhao-Fleming, H.
    Sanchez, C. V.
    Sechi, E.
    Inbarasu, J.
    Wijdicks, E. F.
    Pittock, S. J.
    Chen, J. J.
    Wingerchuk, D. M.
    Weinshenker, B. G.
    Lopez-Chiriboga, S.
    Dubey, D.
    Toledano, M.
    Yadav, H.
    Flanagan, E. P.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 13 - 14
  • [49] Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
    Schindler, Patrick
    Grittner, Ulrike
    Oechtering, Johanna
    Leppert, David
    Siebert, Nadja
    Duchow, Ankelien S.
    Oertel, Frederike C.
    Asseyer, Susanna
    Kuchling, Joseph
    Zimmermann, Hanna G.
    Brandt, Alexander U.
    Benkert, Pascal
    Reindl, Markus
    Jarius, Sven
    Paul, Friedemann
    Bellmann-Strobl, Judith
    Kuhle, Jens
    Ruprecht, Klemens
    JOURNAL OF NEUROINFLAMMATION, 2021, 18 (01)
  • [50] Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder
    Salama, Sara
    Pardo, Santiago
    Levy, Michael
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 30 : 231 - 235